RecruitingNot ApplicableNCT05778903

Maxillary Nerve Blocks in Children - An MRI Study of the Suprazygomatic Approach

Maxillary Nerve Blocks in Children - An MRI Study of the Suprazygomatic


Sponsor

Oslo University Hospital

Enrollment

20 participants

Start Date

Jun 7, 2023

Study Type

INTERVENTIONAL

Conditions

Summary

Ultrasound-guided suprazygomatic maxillary nerve block (SMNB) will be performed in paediatric patients with or without the aid of ultrasound guidance. Magnetic resonance imaging (MRI) is used to visualize the spread of the local anaesthetic (LA) spread after suprazygomatic injection and to verify LA contact with the maxillary nerve in the pterygopalatine fossa (PPF).


Eligibility

Min Age: 10 MonthsMax Age: 24 Months

Inclusion Criteria4

  • Paediatric patients scheduled for cleft palate (CP) surgery with SMNB as part of their perioperative pain treatment
  • American Society of Anesthesiologists physical status 1 - 2
  • Age 10 to 24 months
  • Given informed written consent by legal guardian

Exclusion Criteria5

  • American Society of Anesthesiologists physical status > 2
  • Patients with cranial deformation
  • Patients with concomitant medical treatments or medical conditions interfering with peripheral nerve block treatment
  • Patients with concomitant medical treatments or medical conditions interfering with MRI
  • Patients that are allergic to bupivacaine or other local anaesthetic agents.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERNerve block

Suprazygomatic maxillary nerve block


Locations(1)

Oslo University Hospital

Oslo, Norway

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05778903


Related Trials